HERRIOT TABUTEAU - Chief Executive Officer, Director, 10%+ Owner at Axsome Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director, 10%+ Owner
Issuer Symbol: AXSM on Nasdaq
All Insider Reports: All Insider Reports

HERRIOT TABUTEAU - trading volume in the past year for Axsome Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-491,590	100%	$142.65	-$70,125,820
Net	-491,590	-100%		-$70,125,820

Holdings reported by HERRIOT TABUTEAU for Axsome Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	7,344,500	$1,341,406,090	$182.64	05 Jan 2026	Indirect
Performance Stock Units	28,609	$3,749,782	$131.07	24 Feb 2025	Direct	Common Stock
Restricted Stock Units	28,609	$3,749,782	$131.07	21 Feb 2025	Direct	Common Stock
Common Stock	7,229	$1,231,677	$170.38	07 Jan 2026	Direct
Stock Option (Right to Buy)	32,410	$305,172	$3.50	07 Jan 2026	Direct	Common Stock
Employee Stock Option (Right to Buy)	28,887			21 Feb 2025	Direct	Common Stock

Transactions reported by HERRIOT TABUTEAU for Axsome Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.